“Our ambition is to shape the future of eye care through clinically grounded innovation,” said Dr. Magazzeni, Chief Scientific Officer of Heidelberg Engineering. “This role is pivotal in connecting our scientific strategy with real-world impact for patients and clinicians.”
By bridging clinical science, product innovation, and everyday ophthalmic practice, Dr. Dolz-Marco will help ensure that technologies across the med-tech portfolio address critical unmet needs in ophthalmic diseases and emerging fields such as oculomics. This appointment supports the broader EssilorLuxottica med-tech vision of integrating diagnostics, data, and care to transform eye health and the Groups broader goal of empowering humans.
“I am excited to contribute to a vision that brings together cutting-edge technology and clinical insight,” said Dr. Dolz Marco, Senior Medical Director. “Together, we will drive evidence-based solutions that elevate patient care and unlock new possibilities in ophthalmology.”
Dr. Rosa Dolz-Marco, Senior Medical Director Ophthalmology at Heidelberg Engineering